SUZETTE LYNCH: Open Payments
NPI 1407579428 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,758 in 79 payments from 16 companies in 2025. Trend: 2023 $1,032 · 2024 $1,296 · 2025 $1,758
Food & beverage: $1,758
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $355 |
| PFIZER INC. | 23 | $302 |
| ARGENX US, INC. | 7 | $299 |
| Lundbeck LLC | 8 | $142 |
| Janssen Biotech, Inc. | 7 | $121 |
| Alnylam Pharmaceuticals Inc. | 4 | $107 |
| Neurelis, Inc. | 3 | $92 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
Products named: NURTEC ODT, VYVGART, QULIPTA, VYEPTI, BOTOX, TREMFYA, AMVUTTRA, VALTOCO.
Industry payments across NY — which companies pay providers there.
